AptarGroup(ATR) - 2025 Q4 - Annual Results

Financial Performance - Reported sales for Q4 2025 increased 14% to $963 million compared to $848 million in the prior year, with core sales growing 5%[3] - Reported net income decreased 26% to $74 million, and earnings per share decreased 24% to $1.13; adjusted earnings per share were $1.25[4] - For the year ended December 31, 2025, reported sales increased 5% to $3.78 billion, with core sales also increasing 2%[12] - Net sales for Q4 2025 reached $962.736 million, a 13.5% increase from $848.088 million in Q4 2024[26] - Consolidated net sales for the year ended December 31, 2025, reached $3,777,181,000, an increase from $3,000,000,000 in 2024[32] - Reported net income for the year ended December 31, 2025, was $392,497,000, with a net income margin of 10.4%[32] - Reported net income for the three months ended December 31, 2025, was $74,270,000, with a reported net income margin of 7.7%[31] - Net income attributable to AptarGroup, Inc. for 2025 was $392.789 million, compared to $374.541 million in 2024, reflecting a 4.2% increase[26] Segment Performance - Pharma segment reported sales growth of 10%, driven by strong demand for injectables and systemic nasal drug delivery technologies[5] - Beauty segment reported sales growth of 24%, with core sales growth of 10%, attributed to increased demand for fragrance dispensing[9] - Closures segment reported sales rose 5%, with core sales increasing 1%, supported by a 4% currency benefit[10] Cash Flow and Capital Expenditures - Cash flow from operations for the year was $570 million, with free cash flow at $303 million[16] - Free cash flow for the year ended December 31, 2025, was $302,888, down from $366,932 in 2024[37] - Capital expenditures for 2025 were $270.419 million, slightly down from $276.481 million in 2024[30] - Capital expenditures for the year ended December 31, 2025, were $270,419, slightly down from $276,481 in 2024[37] Shareholder Returns - The company plans to return $206 million to shareholders through share repurchases and dividends in Q4 2025, with a new authorization for up to $600 million in stock repurchases[4][18] Earnings Guidance - For Q1 2026, adjusted earnings per share guidance is expected to be in the range of $1.13 to $1.21, assuming an effective tax rate of 21.0% to 23.0%[17] - The company expects adjusted earnings per share for Q1 2026 to be in the range of $1.13 to $1.21, based on an effective tax rate of 21.0% to 23.0%[40] Balance Sheet - Cash and equivalents increased to $402.424 million in 2025 from $223.844 million in 2024, marking an increase of 80%[28] - Total assets grew to $5.253 billion in 2025, up from $4.432 billion in 2024, indicating a 18.5% increase[28] - Total liabilities increased to $2.540 billion in 2025 from $1.946 billion in 2024, a rise of 30.5%[28] Other Financial Metrics - Adjusted EBITDA margin was 19.8%, down from 23.0% in the prior year, reflecting higher production costs[4] - Adjusted EBITDA for the year ended December 31, 2025, was $815,102,000, representing an adjusted EBITDA margin of 21.6%[32] - Adjusted EBIT for the year ended December 31, 2025, was $527,739,000, reflecting a significant increase from the previous year[32] - Interest expense for the year ended December 31, 2025, totaled $52,737,000, reflecting the company's financing costs[32] - The company reported a net investment loss of $1,328,000 for the three months ended December 31, 2025[31] - The company reported a net loss on remeasurement of equity securities of $483 thousand in 2025, compared to a gain of $1.713 million in 2024[30] - The company reported a net investment loss of $1,713 for the year ended December 31, 2024[33] Share Count - The average number of diluted shares outstanding decreased to 66.725 million in 2025 from 67.691 million in 2024[26] - Average number of diluted shares outstanding for the year 2025 was 66,725, with net income attributable to AptarGroup, Inc. per diluted share at $5.89[36] - Adjusted net income attributable to AptarGroup, Inc. for the year was $382,775, with an adjusted net income per diluted share of $5.74[36]